Data as of Nov 21
| +0.001 / +0.22%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 2.30, with a high estimate of 2.30 and a low estimate of 2.30. The median estimate represents a +400.00% increase from the last price of 0.46.
The current consensus among 1 polled investment analysts is to Buy stock in Titan Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.